Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Aruvant partners with Lonza to manufacture sickle cell disease treatment

pharmaceutical-technologyJanuary 20, 2021

Tag: Aruvant , Lonza , ARU-1801 , SCD , Momentum

PharmaSources Customer Service